2 ML furosemide 10 MG/ML Injection — RxCUI 1719290
RxNorm drug concept · Semantic clinical drug
RxCUI 1719290
Semantic clinical drug · SCD
● Current RxNorm concept 60 FDA products
90 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1719290
Official name2 ML furosemide 10 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asfurosemide 20 MG per 2 ML Injection; furosemide 20 MG in 2 ML Injection
FDA products mapped60
Package NDCs mapped90
Reported Medicaid activity (SDUD)33,815 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Furosemide Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Injectable furosemide is used when you need faster action than a pill can provide, or when you can't take oral medication — for example, in an emergency like acute pulmonary edema...
- Why am I getting this as an injection instead of a pill?
- The biggest things to watch for are signs of dehydration — feeling very dizzy, lightheaded, or faint, especially when you stand up — and muscle cramps or weakness, which can signal...
- What should I watch out for while using furosemide injection?
🕸️ Concept Web — How 2 ML furosemide 10 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
2 ML furosemide 10 MG/ML Injection
RxCUI 1719290 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Furosemide
4603IN
-
Furosemide
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Furosemide Injection
1719285SCDF -
Furosemide Injectable Product
1162712SCDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Furosemide Injection
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Furosemide 10 MG/ML
317376SCDC
-
Furosemide 10 MG/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Furosemide 10 MG/ML
SCDC · 317376 -
Furosemide Injection
SCDF · 1719285 -
Furosemide Injectable Product
SCDG · 1162712
📦 FDA Products & Package NDCs
60 products · 90 package NDCs
90 package NDCs map to RxCUI 1719290 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 63323-0280-16 | 25 VIAL in 1 TRAY (63323-280-16) / 2 mL in 1 VIAL (63323-28... | Furosemide | Fresenius Kabi USA, LLC | 2000-07-12 |
| 63323-0280-26 | 25 VIAL in 1 TRAY (63323-280-26) / 4 mL in 1 VIAL (63323-28... | Furosemide | Fresenius Kabi USA, LLC | 2000-07-12 |
| 63323-0280-36 | 25 VIAL in 1 TRAY (63323-280-36) / 10 mL in 1 VIAL (63323-2... | Furosemide | Fresenius Kabi USA, LLC | 2000-07-12 |
| 68083-0432-05 | 5 VIAL, GLASS in 1 BOX (68083-432-05) / 2 mL in 1 VIAL, GLA... | Furosemide | Gland Pharma Limited | 2020-07-01 |
| 68083-0432-25 | 25 VIAL, GLASS in 1 BOX (68083-432-25) / 2 mL in 1 VIAL, GL... | Furosemide | Gland Pharma Limited | 2020-07-01 |
| 68083-0433-05 | 5 VIAL, GLASS in 1 BOX (68083-433-05) / 4 mL in 1 VIAL, GLA... | Furosemide | Gland Pharma Limited | 2020-07-01 |
| 68083-0433-25 | 25 VIAL, GLASS in 1 BOX (68083-433-25) / 4 mL in 1 VIAL, GL... | Furosemide | Gland Pharma Limited | 2020-07-01 |
| 68083-0434-05 | 5 VIAL, GLASS in 1 BOX (68083-434-05) / 10 mL in 1 VIAL, GL... | Furosemide | Gland Pharma Limited | 2020-07-01 |
| 68083-0434-25 | 25 VIAL, GLASS in 1 BOX (68083-434-25) / 10 mL in 1 VIAL, G... | Furosemide | Gland Pharma Limited | 2020-07-01 |
| 70121-1076-05 | 25 VIAL, GLASS in 1 CARTON (70121-1076-5) / 10 mL in 1 VIAL... | Furosemide | Amneal Pharmaceuticals LLC | 2016-07-25 |
| 70121-1163-05 | 25 VIAL, GLASS in 1 CARTON (70121-1163-5) / 2 mL in 1 VIAL,... | Furosemide | Amneal Pharmaceuticals LLC | 2016-07-25 |
| 70121-1164-05 | 25 VIAL, GLASS in 1 CARTON (70121-1164-5) / 4 mL in 1 VIAL,... | Furosemide | Amneal Pharmaceuticals LLC | 2016-07-25 |
| 70756-0618-05 | 5 VIAL in 1 CARTON (70756-618-05) / 2 mL in 1 VIAL (70756-6... | Furosemide | Lifestar Pharma LLC | 2022-12-17 |
| 70756-0618-25 | 25 VIAL in 1 CARTON (70756-618-25) / 2 mL in 1 VIAL (70756-... | Furosemide | Lifestar Pharma LLC | 2022-12-17 |
| 70756-0619-05 | 5 VIAL in 1 CARTON (70756-619-05) / 4 mL in 1 VIAL (70756-6... | Furosemide | Lifestar Pharma LLC | 2022-12-17 |
| 70756-0619-10 | 10 VIAL in 1 CARTON (70756-619-10) / 4 mL in 1 VIAL (70756-... | Furosemide | Lifestar Pharma LLC | 2022-12-17 |
| 70756-0619-25 | 25 VIAL in 1 CARTON (70756-619-25) / 4 mL in 1 VIAL (70756-... | Furosemide | Lifestar Pharma LLC | 2022-12-17 |
| 70756-0620-10 | 10 VIAL in 1 CARTON (70756-620-10) / 10 mL in 1 VIAL (70756... | Furosemide | Lifestar Pharma LLC | 2022-12-17 |
| 70756-0620-25 | 25 VIAL in 1 CARTON (70756-620-25) / 10 mL in 1 VIAL (70756... | Furosemide | Lifestar Pharma LLC | 2022-12-17 |
| 71288-0203-03 | 25 VIAL, SINGLE-DOSE in 1 CARTON (71288-203-03) / 2 mL in 1... | Furosemide | Meitheal Pharmaceuticals Inc. | 2022-01-27 |
| 71288-0203-05 | 25 VIAL, SINGLE-DOSE in 1 CARTON (71288-203-05) / 4 mL in 1... | Furosemide | Meitheal Pharmaceuticals Inc. | 2022-01-27 |
| 71288-0203-11 | 25 VIAL, SINGLE-DOSE in 1 CARTON (71288-203-11) / 10 mL in... | Furosemide | Meitheal Pharmaceuticals Inc. | 2022-01-27 |
| 71288-0203-92 | 25 VIAL, SINGLE-DOSE in 1 CARTON (71288-203-92) / 2 mL in 1... | Furosemide | Meitheal Pharmaceuticals Inc. | 2022-01-27 |
| 71288-0203-94 | 25 VIAL, SINGLE-DOSE in 1 CARTON (71288-203-94) / 10 mL in... | Furosemide | Meitheal Pharmaceuticals Inc. | 2022-01-27 |
| 71872-7059-01 | 1 VIAL, GLASS in 1 BAG (71872-7059-1) / 2 mL in 1 VIAL, GLA... | FUROSEMIDE | Medical Purchasing Solutions, LLC | 2018-03-02 |
| 71872-7236-01 | 1 VIAL in 1 BAG (71872-7236-1) / 2 mL in 1 VIAL | Furosemide | Medical Purchasing Solutions, LLC | 2020-12-15 |
| 71872-7295-01 | 1 VIAL in 1 BAG (71872-7295-1) / 2 mL in 1 VIAL | Furosemide | Medical Purchasing Solutions, LLC | 2022-07-25 |
| 72603-0133-25 | 25 VIAL in 1 CARTON (72603-133-25) / 2 mL in 1 VIAL (72603-... | Furosemide | NorthStar Rx LLC | 2023-02-01 |
| 72603-0251-25 | 25 VIAL in 1 CARTON (72603-251-25) / 4 mL in 1 VIAL (72603-... | Furosemide | NorthStar Rx LLC | 2023-02-01 |
| 72603-0474-25 | 25 VIAL in 1 CARTON (72603-474-25) / 10 mL in 1 VIAL (72603... | Furosemide | NorthStar Rx LLC | 2023-02-01 |
| 73043-0022-01 | 25 VIAL, GLASS in 1 BOX (73043-022-01) / 2 mL in 1 VIAL, GL... | FUROSEMIDE | Devatis Inc. | 2024-08-10 |
| 73043-0023-01 | 25 VIAL, GLASS in 1 BOX (73043-023-01) / 4 mL in 1 VIAL, GL... | FUROSEMIDE | Devatis Inc. | 2024-08-10 |
| 73043-0024-01 | 25 VIAL, GLASS in 1 BOX (73043-024-01) / 10 mL in 1 VIAL, G... | FUROSEMIDE | Devatis Inc. | 2024-08-10 |
| 73542-0101-25 | 25 VIAL in 1 CARTON (73542-101-25) / 2 mL in 1 VIAL | Furosemide | Maiva Pharma Private Limited | 2025-06-16 |
| 73542-0102-25 | 25 VIAL in 1 CARTON (73542-102-25) / 4 mL in 1 VIAL | Furosemide | Maiva Pharma Private Limited | 2025-06-16 |
| 73542-0103-25 | 25 VIAL in 1 CARTON (73542-103-25) / 10 mL in 1 VIAL | Furosemide | Maiva Pharma Private Limited | 2025-06-16 |
| 81565-0201-02 | 25 VIAL in 1 TRAY (81565-201-02) / 2 mL in 1 VIAL (81565-20... | Furosemide | Phlow Corporation | 2022-02-01 |
| 83634-0302-02 | 25 VIAL, SINGLE-DOSE in 1 CARTON (83634-302-02) / 2 mL in 1... | Furosemide | Avenacy Inc. | 2024-03-15 |
| 83634-0302-04 | 25 VIAL, SINGLE-DOSE in 1 CARTON (83634-302-04) / 4 mL in 1... | Furosemide | Avenacy Inc. | 2024-03-15 |
| 83634-0302-10 | 25 VIAL, SINGLE-DOSE in 1 CARTON (83634-302-10) / 10 mL in... | Furosemide | Avenacy Inc. | 2024-03-15 |
Observed labelers:
Lifestar Pharma LLC (7) ·
Baxter Healthcare Corporation (6) ·
Fresenius Kabi USA, LLC (6) ·
Gland Pharma Limited (6) ·
Hospira, Inc. (6) ·
Sagent Pharmaceuticals (6)
· +17 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J1938 | Inj, furosemide, 1 mg | 49 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.